Finabase

    • Login
    • Categories
    Home Watchlists Portfolios Map Forex Futures Crypto Comparisons Alerts Screeners Backtests vTrading Settings Forum
    1. Home
    2. BCRX
    • Alert
    • Note
    BCRX
    BioCryst Pharmaceuticals, Inc.
    14.20
    -
    0.05
    0.35%
    14 x 14.27
    12 x 14.30
    bid
    ask
    10:07 AM
    timesize
    Bearish 30
    Bullish 77
    sentiment
    14.14
    day range
    14.37
    7.61
    52 week range
    19.99
    10:07 AM
    V: 201.92K
    C: 14.20
    L: 14.14
    H: 14.37
    O: 14.34
    loading chart ...
    • 1d
    • 5d
    • 1m
    • 3m
    • 6m
    • ytd
    • 1y
    • 2y
    • 5y
    • max
    • PDF
    • Full Chart
    • Stats
    • Watchlist
    • Portfolio
    Prev Close14.25
    Open14.34
    Low14.14
    High14.37
    Volume201.92K
    Avg. Volume3.10M
    Market Cap2.65B
    Inst. Own83.89%
    Beta2.20
    Short Ratio12.23
    Div & Yield0.00 /
    EPS-1.07
    P/E
    1yr Target18.60
    50day MA11.44
    200day MA12.90
    ^DJI
    Dow Jones Industrial Average
    33853.90
    10:08 AM
    -
    126.40
    0.37%
    ^IXIC
    NASDAQ Composite
    12898.90
    10:07 AM
    -
    39.20
    0.30%
    ^GSPC
    S&P 500
    4264.85
    10:07 AM
    -
    9.19
    0.22%
    AAPL
    Apple Inc.
    173.44
    10:07 AM
    8 x 174.01
    9 x 173.90
    -
    1.11
    0.64%
    GOOG
    Alphabet Inc.
    120.06
    10:07 AM
    9 x 120.08
    40 x 120.12
    -
    0.26
    0.21%
    AMZN
    Amazon.com, Inc.
    141.11
    10:08 AM
    10 x 141.13
    9 x 141.18
    -
    0.99
    0.70%
    MSFT
    Microsoft Corporation
    290.06
    10:07 AM
    13 x 289.96
    8 x 290.03
    -
    1.26
    0.43%
    BABA
    Alibaba Group Holding Limited
    89.06
    10:08 AM
    13 x 88.94
    10 x 88.95
    -
    0.71
    0.79%
    NFLX
    Netflix, Inc.
    240.99
    10:07 AM
    10 x 240.00
    9 x 240.41
    -
    0.16
    0.07%
    TSLA
    Tesla, Inc.
    909.00
    10:07 AM
    10 x 911.47
    14 x 911.87
    -
    2.99
    0.33%
    NVDA
    NVIDIA Corporation
    184.68
    10:07 AM
    11 x 184.28
    8 x 184.12
    +
    1.33
    0.72%
    AMD
    Advanced Micro Devices, Inc.
    98.33
    10:08 AM
    8 x 98.25
    8 x 98.25
    +
    0.06
    0.06%
    MU
    Micron Technology, Inc.
    61.99
    10:07 AM
    14 x 61.75
    9 x 61.77
    +
    0.38
    0.61%
    SPY
    SPDR S&P 500 ETF Trust
    425.90
    10:07 AM
    10 x 426.18
    11 x 426.10
    -
    0.75
    0.18%
    TQQQ
    ProShares UltraPro QQQ
    37.03
    10:07 AM
    8 x 36.96
    14 x 36.97
    -
    0.27
    0.71%
    BRK-A
    Berkshire Hathaway Inc.
    455596.00
    10:07 AM
    10 x 456582.00
    11 x 457253.00
    -
    1682.00
    0.37%
    Day Gain
    Gain
    Market Val
    Costs
    Cash
    Portfolio
    Realized
    Dividend
    • Summary
    • Discussion
    • News
    • Signals
    • Financials
    • Alerts
    • Notes
    • Chart
    • Backtest
    News ...
    2022-08-18 | NDAQ:BCRX | Press Release | BioCryst Pharmaceuticals Inc. stockhouse.com •
    Russell Investments Group Ltd. Has $1.31 Million Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) defenseworld.net •
    BioCryst Pharmaceuticals Inc (BCRX) Down 3.35% in Premarket Trading investorsobserver.com •
    Ginkgo Bioworks Holdings Inc (DNA) Down 3.48% in Premarket Trading investorsobserver.com •
    BioCryst Announces Approval of ORLADEYO® (berotralstat) in Saudi Arabia marketscreener.com •
    State Board of Administration of Florida Retirement System Sells 13040 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) defenseworld.net •
    Profile ...
    BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
    Earning ...
    Date For Estimate Reported Surprise surprise %
    2022-08-04 2022-06 -0.36 -0.32 0.04 11.11%
    2022-05-05 2022-03 -0.39 -0.4 -0.01 -2.56%
    2022-02-23 2021-12 -0.31 -0.4 -0.09 -29.03%
    2021-11-03 2021-09 -0.3 -0.33 -0.03 -10.00%
    2021-08-05 2021-06 -0.22 -0.24 -0.02 -9.09%
    2021-05-06 2021-03 -0.26 -0.36 -0.1 -38.46%
    Upgrade / Downgrade ...
    Date Firm Action From To
    2022-08-08 Oppenheimer Downgrade Outperform Perform
    2022-08-05 Barclays Upgrade Equal-Weight
    2022-08-05 Oppenheimer Downgrade Outperform Perform
    2022-08-05 Evercore ISI Group Downgrade Outperform In-Line
    2022-04-18 Barclays Downgrade Overweight Equal-Weight
    2022-04-12 RBC Capital Upgrade Sector Perform
    Insider Holder ...
    Date Name Relation Quantity Description
    2022-06-06 ABERCROMBIE GEORGE B Director 12.87K Stock Award(Grant)
    2022-06-06 ASELAGE STEPHEN J Director 46.59K Stock Award(Grant)
    2022-06-06 GALSON STEVEN K Director 12.87K Stock Award(Grant)
    2022-06-06 HEGGIE THERESA Director 30.23K Stock Award(Grant)
    2022-06-06 HUTSON NANCY J Director 77.94K Stock Award(Grant)
    2022-06-06 INGRAM ROBERT ALEXANDER Director 95.00K Stock Award(Grant)
    Institution Ownership ...
    Report Date Organization Position Value Percentage
    2022-06-29 Blackrock Inc. 13.99M 199.32M 7.52%
    2022-06-29 Vanguard Group, Inc. (The) 13.81M 196.79M 7.43%
    2022-03-30 Baker Brothers Advisors, LLC 12.71M 181.13M 6.84%
    2022-03-30 State Street Corporation 7.46M 106.34M 4.01%
    2022-06-29 Pictet Asset Management SA 6.05M 86.17M 3.25%
    2022-06-29 Fisher Asset Management, LLC 5.22M 74.34M 2.81%
    Fund Ownership ...
    Report Date Organization Position Value Percentage
    2022-06-29 SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF 7.26M 103.50M 3.91%
    2022-03-30 Vanguard Total Stock Market Index Fund 5.26M 74.97M 2.83%
    2022-06-29 iShares Russell 2000 ETF 4.17M 59.43M 2.25%
    2022-05-30 Fidelity Select Portfolios - Biotechnology 4.19M 59.74M 2.25%
    2022-04-29 Lord Abbett Developing Growth Fund 2.45M 34.94M 1.32%
    2022-03-30 Vanguard Extended Market Index Fund 2.39M 34.03M 1.29%
    Dividend ...
    Dividend Date
    0 2014-06-11
    0 2014-06-05
    0 2014-05-20
    0 2014-05-16
    0 2014-04-02
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • oriley.services
      oriley.services last edited by

      $BCRX I sure hope @Imakook gives us some direction today

      1 Reply Last reply Reply Quote 0
      • oriley.services
        oriley.services last edited by

        $BCRX I had 31K shares sitting right here a few day’s ago…does this concern any of you?

        1 Reply Last reply Reply Quote 0
        • oriley.services
          oriley.services last edited by

          $BCRX @Larry Thank you for your daily feed of key numbers /news /observations your a machine you never sleep. I’m sure I speak for many keep it up.

          1 Reply Last reply Reply Quote 0
          • oriley.services
            oriley.services last edited by

            $BCRX Great we’ve got Imacouk sharing knowledge this morning it’s gona be a good day?

            1 Reply Last reply Reply Quote 0
            • oriley.services
              oriley.services last edited by

              $BCRX Where is this guy mike smith getting subway sandwiches for $4.00 in Dallas there all $5.50.

              1 Reply Last reply Reply Quote 0
              • oriley.services
                oriley.services last edited by

                $BCRX Well since my account is going to hell in a hand basket and my family relies on me I’m going to go to my beach house for the week and think about it………now what was I thinking about? Heaven help us all.

                1 Reply Last reply Reply Quote 0
                • oriley.services
                  oriley.services last edited by

                  $BCRX $4.67 how wet it is!

                  1 Reply Last reply Reply Quote 0
                  • oriley.services
                    oriley.services last edited by

                    $BCRX Wow Mikey this thing is gona take off …run and tell your mommy

                    1 Reply Last reply Reply Quote 0
                    • oriley.services
                      oriley.services last edited by

                      $BCRX I needed a smile…thanks

                      1 Reply Last reply Reply Quote 0
                      • oriley.services
                        oriley.services last edited by

                        $BCRX

                        Who’s it gonna bbbe

                        1 Reply Last reply Reply Quote 0
                        • oriley.services
                          oriley.services last edited by

                          $BCRX Let my people go you raskley rats

                          1 Reply Last reply Reply Quote 0
                          • oriley.services
                            oriley.services last edited by

                            $BCRX BINGO

                            1 Reply Last reply Reply Quote 0
                            • oriley.services
                              oriley.services last edited by

                              $BCRX Creatine levels are leveling out …good news

                              1 Reply Last reply Reply Quote 0
                              • oriley.services
                                oriley.services last edited by

                                ‘$BCRX I’m glad to see someone else is concerned about something not just the Sea Turd

                                1 Reply Last reply Reply Quote 0
                                • oriley.services
                                  oriley.services last edited by

                                  $BCRX @Harrington with all the trash you spout this is about as far as your going to get buddy

                                  1 Reply Last reply Reply Quote 0
                                  • oriley.services
                                    oriley.services last edited by

                                    $BCRX I think it’s time

                                    1 Reply Last reply Reply Quote 0
                                    • oriley.services
                                      oriley.services last edited by

                                      $BCRX BASTARDS BASTARDS BASTARDS……….

                                      1 Reply Last reply Reply Quote 0
                                      • oriley.services
                                        oriley.services last edited by

                                        $BCRX So much for that 1k share add at “this is going to be the bottom” price of 9.97.

                                        1 Reply Last reply Reply Quote 0
                                        • oriley.services
                                          oriley.services last edited by

                                          $BCRX You ever felt like you’ve been stabbed in the back…just wondering?

                                          1 Reply Last reply Reply Quote 0
                                          • 1
                                          • 2
                                          • 3
                                          • 4
                                          • 5
                                          • 18
                                          • 19
                                          • 1 / 19
                                          • First post
                                            Last post
                                          • 2022-08-18 | NDAQ:BCRX | Press Release | BioCryst Pharmaceuticals Inc.
                                            stockhouse.com •

                                          • Russell Investments Group Ltd. Has $1.31 Million Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
                                            defenseworld.net •

                                          • BioCryst Pharmaceuticals Inc (BCRX) Down 3.35% in Premarket Trading
                                            investorsobserver.com •

                                          • Ginkgo Bioworks Holdings Inc (DNA) Down 3.48% in Premarket Trading
                                            investorsobserver.com •

                                          • BioCryst Announces Approval of ORLADEYO® (berotralstat) in Saudi Arabia
                                            marketscreener.com •

                                          • State Board of Administration of Florida Retirement System Sells 13040 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
                                            defenseworld.net •

                                          • BioCryst Pharmaceuticals, Inc. to Post Q3 2022 Earnings of ($0.07) Per Share, Jefferies Financial Group Forecasts (NASDAQ:BCRX)
                                            marketbeat.com •

                                          • Top 5 2nd Quarter Trades of Biondo Investment Advisors, LLC
                                            gurufocus.com •

                                          • Options Bulls Blast Phama Stock on Lifted Clinical Hold
                                            schaeffersresearch.com •

                                          • BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q2 Results - Earnings Call Transcript
                                            seekingalpha.com •

                                          • Why BioCryst Pharmaceuticals Stock Is Bolting Higher Today
                                            fool.com •

                                          • 3 Fast-Growing Stocks to Buy Now
                                            fool.com •

                                          • BioCryst to Report Second Quarter 2022 Financial Results on August 4
                                            globenewswire.com •

                                          • BioCryst to Present at Upcoming Investor Conference
                                            globenewswire.com •

                                          • BioCryst: A Prudent Diversification
                                            seekingalpha.com •

                                          • Strength Seen in BioCryst (BCRX): Can Its 5.5% Jump Turn into More Strength?
                                            zacks.com •

                                          • Why BioCryst Pharmaceuticals Topped the Market Today
                                            fool.com •

                                          • 7 Cheap Biotech Stocks to Buy Now
                                            investorplace.com •

                                          • BioCryst to Present at Upcoming Investor Conferences
                                            globenewswire.com •

                                          • Why BioCryst Stock Lost Nearly 4% of Its Value Today
                                            fool.com •

                                          • Why BioCryst Stock Shot Nearly 5% Higher Today
                                            fool.com •

                                          • BioCryst to Report First Quarter 2022 Financial Results on May 5
                                            globenewswire.com •

                                          • Why BioCryst Pharmaceuticals Stock Sank Today
                                            fool.com •

                                          • Why BioChryst Pharmaceuticals' Stock Jumped 14.7% This Week
                                            fool.com •

                                          • Strength Seen in BioCryst (BCRX): Can Its 15.2% Jump Turn into More Strength?
                                            zacks.com •

                                          • BioCryst (BCRX) Pauses Enrolment in Key Studies, Stock Down
                                            zacks.com •

                                          • Why BioCryst Pharmaceuticals Stock Is Falling
                                            benzinga.com •

                                          • BioCryst to Present at Upcoming Investor Conference
                                            globenewswire.com •

                                          • Read Here Why Did BioCryst Stopped Enrollment In BCX9930 Studies In Rare Blood Disorder
                                            benzinga.com •

                                          • Why BioCryst Pharmaceuticals Stock Is Plunging Today
                                            benzinga.com •

                                          • Why BioCryst Pharmaceuticals Stock Slid Today
                                            fool.com •

                                          • BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q4 2021 Results - Earnings Call Transcript
                                            seekingalpha.com •

                                          • BioCryst Pharmaceuticals (BCRX) Reports Q4 Loss, Misses Revenue Estimates
                                            zacks.com •

                                          • Is BioCryst (BCRX) Ready to Breakout to New Highs on Recent Catalysts?
                                            benzinga.com •

                                          • Updated Guidance And Royalty Pharma Financing Demolish Short Thesis For BioCryst Pharmaceuticals
                                            seekingalpha.com •

                                          • BioCryst to Present New ORLADEYO® (berotralstat) Data at 2022 American Academy of Allergy, Asthma & Immunology Annual Meeting
                                            globenewswire.com •

                                          • Why BioCryst Pharmaceuticals Stock Is Skyrocketing This Week
                                            fool.com •

                                          • BioCryst Pharmaceuticals Stock (BCRX): Why The Price Surged Today
                                            pulse2.com •

                                          • Why BioCryst Pharmaceuticals Stock Is Jumping on Monday
                                            fool.com •

                                          • BioCryst Provides Tremendous Option Value
                                            seekingalpha.com •

                                          • BioCryst: Great Execution, Impressive Pipeline, Long Cash Runway
                                            seekingalpha.com •

                                          • BioCryst (BCRX) Begins Enrollment in PNH Study on BCX9930
                                            zacks.com •

                                          • BioCryst Shares Gain As Royalty Pharma Buys Additional Interests In BCX9930, Orladeyo
                                            benzinga.com •

                                          • 7 Top Growth Stocks to Buy as We Step Into November
                                            investorplace.com •

                                          • BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q3 2021 Results - Earnings Call Transcript
                                            seekingalpha.com •

                                          • Here's Why BioCryst Pharmaceuticals Stock Is Losing Ground Today
                                            fool.com •

                                          • BioCryst to Present New ORLADEYO® (berotralstat) Data at Annual Scientific Meeting of American College of Allergy, Asthma & Immunology
                                            globenewswire.com •

                                          • BioCryst to Report Third Quarter 2021 Financial Results on November 3
                                            globenewswire.com •

                                          • 7 Best Growth Stocks to Buy and Hold for the Next 10 Years
                                            investorplace.com •

                                          • 2 Super-Charged Growth Stocks to Buy Now
                                            fool.com •

                                          • BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
                                            globenewswire.com •

                                          • 3 Biotech Stocks Wall Street Thinks Could Rise 44% or Better
                                            fool.com •

                                          • NICE Recommends BioCryst's Hereditary Angioedema Med
                                            benzinga.com •

                                          • NICE Recommends BioCryst's ORLADEYO® (berotralstat), the First Oral, Once-daily Therapy, to Prevent Attacks in HAE Patients in the UK
                                            globenewswire.com •

                                          • What Wall Street Still Has Wrong. BioCryst To Become Next Rare Disease Giant
                                            seekingalpha.com •

                                          • BioCryst to Present at Upcoming Investor Conferences
                                            globenewswire.com •

                                          • BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
                                            globenewswire.com •

                                          • US Government Exercises Option To Buy Additional Doses Of BioCryst's Flu Med
                                            benzinga.com •

                                          • U.S. Government Exercises Option to Purchase Additional RAPIVAB® (peramivir injection) from BioCryst for Delivery to Strategic National Stockpile
                                            globenewswire.com •

                                          • BioCryst Appoints Dr. Steven Galson to Board of Directors
                                            globenewswire.com •

                                          • BioCryst Announces Acceptance of Regulatory Applications for ORLADEYO® (berotralstat) by Health Canada and Swissmedic
                                            globenewswire.com •

                                          • 2 Soaring Biotech Stocks With More Fuel in the Tank
                                            fool.com •

                                          • BioCryst Stock Jumps After Pulling Out $200M Equity Raise
                                            benzinga.com •

                                          • BioCryst Withdraws Public Offering
                                            globenewswire.com •

                                          • Why BioCryst Pharmaceuticals Rose 8% on Thursday
                                            fool.com •

                                          • BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q2 2021 Results - Earnings Call Transcript
                                            seekingalpha.com •

                                          • BioCryst Pharma Stock Heads Higher Thursday: Here's Why
                                            benzinga.com •

                                          • Tuesday Afternoon Analyst Upgrades and Downgrades: Exxon Mobil, First Solar, Tesla and More
                                            247wallst.com •

                                          • 3 Biotech Stocks That Could Rocket Higher
                                            fool.com •

                                          • BioCryst to Report Second Quarter 2021 Financial Results on August 5
                                            globenewswire.com •

                                          • BioCryst Pharmaceuticals - Orladeyo Revenue Will Drive Share Price
                                            seekingalpha.com •

                                          • BioCryst Outlines Pivotal Trial Designs For BCX9930 In Rare Blood Disorder
                                            benzinga.com •

                                          • BioCryst Shares 96-Week Orladeyo Data Highlighting 80% Reduction In HAE Attacks
                                            benzinga.com •

                                          • BioCryst Reports 96-week Data from APeX-2 Showing ORLADEYO®(berotralstat) Reduced HAE Attack Rate by 80 Percent from Baseline
                                            globenewswire.com •

                                          • ORLADEYO™ (berotralstat) Data to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress
                                            globenewswire.com •

                                          • Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
                                            seekingalpha.com •

                                          • Up 126% in 2021, Could BioCryst Pharmaceuticals Go Even Higher?
                                            fool.com •

                                          • BioCryst Announces Acceptance and Accelerated Review of the ORLADEYO™ (berotralstat) Marketing Application by the Israeli Ministry of Health
                                            globenewswire.com •

                                          • 7 A-Rated Biotech Stocks to Buy Now
                                            investorplace.com •

                                          • BioCryst Pharmaceuticals: An Orphan Disease Innovator With More Upside
                                            seekingalpha.com •

                                          • Forget AMC, GameStop: Analyst Names 2 New Reddit Stocks Traders Should Watch
                                            benzinga.com •

                                          • Is BioCryst a Good Stock to Buy Now?
                                            fool.com •

                                          • Is the Options Market Predicting a Spike in BioCryst (BCRX) Stock?
                                            zacks.com •

                                          • Why BioCryst Pharmaceuticals Stock Is Jumping Today
                                            fool.com •

                                          • BioCryst Receives UK Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
                                            globenewswire.com •

                                          • Strength Seen in BioCryst (BCRX): Can Its 21% Jump Turn into More Strength?
                                            zacks.com •

                                          • BioCryst: Solid Delivery And Follow Through
                                            seekingalpha.com •

                                          • BCRX Stock: 24.35% Increase (From $10.68 To $13.28) Intraday Explanation
                                            pulse2.com •

                                          • BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q1 2021 Results - Earnings Call Transcript
                                            seekingalpha.com •

                                          • BioCryst Shares Trading Higher As Q1 Sales Beat Was Supported By Orladeyo Revenues
                                            benzinga.com •

                                          • Why BioCryst Pharmaceuticals Stock Is Soaring Today
                                            fool.com •

                                          • BioCryst Receives European Commission Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
                                            globenewswire.com •

                                          • BioCryst Announces Approval of Japanese NHI Price Listing of ORLADEYO™ (berotralstat) for Prophylactic Treatment of Hereditary Angioedema
                                            globenewswire.com •

                                          • BioCryst to Present at 20th Annual Needham Virtual Healthcare Conference
                                            globenewswire.com •

                                          • BCRX Stock Price: $15 Target By Piper Sandler
                                            pulse2.com •

                                          • BioCryst Technical Levels To Watch
                                            benzinga.com •

                                          • FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings
                                            benzinga.com •

                                          • BioCryst Appoints Helen Thackray, M.D., as Chief Research and Development Officer
                                            globenewswire.com •

                                          • BioCryst, Editas, Groupon, Sunrun, Twitter and More of Monday Afternoon's Analyst Calls
                                            247wallst.com •

                                          • BioCryst's Orladeyo Wins EU Positive Opinion For Hereditary Angioedema
                                            benzinga.com •

                                          Copyright © 2022 finabase.io